Correlation Between Axsome Therapeutics and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Axsome Therapeutics and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axsome Therapeutics and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axsome Therapeutics and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Axsome Therapeutics and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axsome Therapeutics with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axsome Therapeutics and Hepion Pharmaceuticals.
Diversification Opportunities for Axsome Therapeutics and Hepion Pharmaceuticals
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Axsome and Hepion is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Axsome Therapeutics and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Axsome Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axsome Therapeutics are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Axsome Therapeutics i.e., Axsome Therapeutics and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Axsome Therapeutics and Hepion Pharmaceuticals
Given the investment horizon of 90 days Axsome Therapeutics is expected to generate 0.67 times more return on investment than Hepion Pharmaceuticals. However, Axsome Therapeutics is 1.49 times less risky than Hepion Pharmaceuticals. It trades about 0.17 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.19 per unit of risk. If you would invest 10,885 in Axsome Therapeutics on December 1, 2024 and sell it today you would earn a total of 1,869 from holding Axsome Therapeutics or generate 17.17% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Axsome Therapeutics vs. Hepion Pharmaceuticals
Performance |
Timeline |
Axsome Therapeutics |
Hepion Pharmaceuticals |
Axsome Therapeutics and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Axsome Therapeutics and Hepion Pharmaceuticals
The main advantage of trading using opposite Axsome Therapeutics and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axsome Therapeutics position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.Axsome Therapeutics vs. Incyte | Axsome Therapeutics vs. Sarepta Therapeutics | Axsome Therapeutics vs. ACADIA Pharmaceuticals | Axsome Therapeutics vs. Viking Therapeutics |
Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |